Canopy Growth's Auditor Exit Casts a Long Shadow Over a Sharper Quarterly Performance

Canopy Growth posts Q1 revenue growth and margin gains, but auditor resignation and restated financials keep governance concerns alive.

The numbers Canopy Growth posted on Friday told a story of steady operational repair: revenue climbing, losses compressing, and gross margins taking a meaningful leap. But the disclosure that landed alongside those figures — the abrupt resignation of the company's auditor — has left investors weighing whether the improving fundamentals can survive the persistent questions hanging over the company's financial reporting.

Shares responded with a shrug on Monday, closing at €0.8400, up just 0.57 percent from the prior session. The muted reaction suggests the market has already priced in the competing narratives at play: a business making genuine headway on costs, and a governance overhang that refuses to dissipate.

Margin Gains Tell the Real Turnaround Story

The headline numbers for the first quarter of fiscal 2027 were encouraging on multiple fronts. Consolidated net revenue climbed 13 percent to C$81.2 million, with the cannabis segment contributing C$65.1 million — a 14 percent year-over-year increase.

The margin picture was arguably the most striking element. Adjusted gross margin jumped from 25 percent in the year-ago quarter to 31 percent, driven in large part by a dramatic improvement at Storz & Bickel, the company's vaporizer division. That unit saw its gross margin surge from 29 percent to 48 percent, helped by cost rationalization and the recovery of a portion of previously paid US tariffs.

The bottom line also showed meaningful improvement. The adjusted EBITDA loss narrowed by 59 percent to C$3.2 million, while the net loss contracted 68 percent to C$14.6 million. On a per-share basis, the loss of -$0.02 came in half as deep as the -$0.04 analysts had anticipated.

Segment-level growth was broad-based. Canada's medical cannabis business advanced 22 percent, buoyed by an expanding base of insured patients and the contribution from the MTL Cannabis acquisition. The Canadian recreational market grew 10 percent, matching the pace of international markets.

An Auditor's Exit and Restated Financials

The operational progress, however, was overshadowed by the announcement that PKF O'Connor Davies had resigned as auditor with immediate effect — the same day the results were released. The audit committee has appointed MNP LLP as successor for the fiscal year ending March 31, 2027, but the circumstances of the departure are difficult to brush aside.

PKF O'Connor Davies had issued an adverse opinion on the company's internal control over financial reporting as of March 31, 2026, flagging a material weakness in the review of technical accounting matters, particularly around the classification of equity-linked instruments. Canopy Growth also reaffirmed that certain consolidated financial statements for fiscal 2024 and 2025, along with several quarterly reports, should no longer be relied upon due to non-cash technical errors in accounting for share-based warrants with US dollar-denominated exercise prices.

The restatement issue is not new, but the auditor's resignation injects fresh uncertainty into a company that has been telling investors a profitability inflection is within reach. A separate legal matter adds to the picture: a proposed partial settlement of C$3.5 million in a class action against Canopy Growth, former executives David Klein and Judy Hong, and former auditor KPMG LLP, which still requires approval from the Ontario Superior Court.

MTL Integration and the UK Opportunity

Management's focus remains on extracting value from the MTL Cannabis acquisition, with annual synergies targeted at C$8 million. The company says it is making progress on cultivation and supply chain integration and sees room to strengthen the platform further over the medium term.

Internationally, the UK is emerging as a near-term catalyst. Canopy Growth expects flower shipments to Britain to commence shortly, with initial revenue contributions anticipated in the second half of fiscal 2027.

Guidance remains unchanged: the company still targets positive adjusted EBITDA for the current fiscal year, with gross margin expected to reach the mid-30 percent range in the near term and approach 50 percent over the longer haul.

A Stock Still Searching for Its Floor

Despite the operational improvements, the equity continues to trade with a distinctly cautious tone. The shares sit roughly 58 percent below their 52-week high and about 11.6 percent under the 200-day moving average — a technical picture that suggests the market has yet to be convinced the recovery is durable. At the same time, the stock has built a 12 percent cushion above its 52-week low of €0.7500, reached in late March. The company's market capitalization stands at approximately €374.52 million, a far cry from the valuations that once made it a sector heavyweight.

CEO Luc Mongeau is scheduled to present at the Canaccord Genuity Growth Conference in Boston on Tuesday at 12:00 pm local time — an opportunity to address institutional investors directly on the MTL integration, the EBITDA trajectory, and, inevitably, the accounting questions that now sit at the center of the company's story. For a management team trying to convince the market that the operational turnaround deserves more credit than the governance overhang suggests, it will be a pivotal audience.